T0	Outcomes 578 607	plasma concentrations of IL-6
T1	Outcomes 612 616	IL-8
T2	Outcomes 783 951	hemodynamics (cardiac index, systemic vascular resistance index, heart rate, and mean arterial pressure); change of hematology and coagulation function; organ function;
T3	Outcomes 960 1009	sequential organ failure assessment (SOFA) score.
T4	Outcomes 1010 1045	Hospital, 28-day, and ICU mortality
T5	Outcomes 1114 1133	significant removal
T6	Outcomes 1137 1157	plasma IL-6 and IL-8
T7	Outcomes 1231 1252	significant increases
T8	Outcomes 1256 1370	cardiac index, systemic vascular resistant index, fast withdrawal of vasoactive agents and decreases in heart rate
T9	Outcomes 1437 1459	significant difference
T10	Outcomes 1482 1499	organ dysfunction
T11	Outcomes 1515 1526	SOFA scores
T12	Outcomes 1654 1676	significant difference
T13	Outcomes 1699 1809	28-day mortality, hospital mortality, or length of hospital stay, but ICU mortality and the length of ICU stay
T14	Outcomes 1840 1848	reduced.
T15	Outcomes 1938 2007	organ dysfunction, ICU mortality, and shorten the length of ICU stay.
T16	Outcomes 2071 2084	IL-6 and IL-8